Answers - Finance

Your trade signal has been given, by a chart system or fundamental analysis of entry, exit, and stop prices hav

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

e been set, and all that is left to do is make the phone call to your broker, or hit your button your computer

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

keyboard. But at this point, all the doubt and second-guessing comes to a head, and the trade never gets place

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

d. Sound familiar? It's probably the most common heartache faced by traders, and is only compounded when it tur

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ns out that it would have been a great trade. This is a tough issue, and unfortunately there is not an easy ans

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

wer. However, there are some tools that can help you work past the problem.

Let us start out by assuming that

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

you have confidence in your system and it has worked well for you in the past. The next step, of course, is to

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ctually place a trade. That sometimes can be easier said than done. You suddenly can think of a million reasons

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

why the trade might not work. Sometimes you might think that one or two of your indicators do not match up to

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

the rest of the signs saying to get in. You might start thinking about the consequences if you are wrong. Whate

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ver the thoughts, they can be tough to deal with at times. Uncertainty is a powerful emotion that can weaken th

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

e best of us. You are occasionally going to be wrong, so get used to that. No matter how good your system, the

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

system is designed to show you the chances of a certain outcome. Since no outcome in the market is certain, the

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

system will be wrong at times. To battle the thoughts of the consequences of being wrong, just remember that s

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

op losses are designed to minimize those consequences.

The next time you catch yourself thinking thoughts that

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

might derail your trade, go step by step through those thoughts. The trading system has a couple of signals th

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

at do not match the rest? Remember that the signals will never all match up. What happens if I am wrong? Your s

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

top will take you out and you will live to trade another day.

Pulling the trigger on the actual trade may be t

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

he most difficult part for many, but it is also the whole point of trading. It is better to get into the trade

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

and either profit from it or learn a lesson for the future than it is to sit back and let the market pass you b

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102186/answers-Mental-Barrier-of-a-Trade-Entry.html">Mental Barrier of a Trade Entry</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/102186/answers-Mental-Barrier-of-a-Trade-Entry.html]Mental Barrier of a Trade Entry[/url]

There are people making incredible livings through the Internet. Yet, the majority of people never will. There are some very simple reasons for this. The misconceptions could be costing you a fortune.

Over Selling could lose the sale. Know your customer before giving the sales pitch.

Tags

Links

Answers - Mental Barrier of a Trade Entry

Related Articles: